The University of Chicago Header Logo

Connection

Robert Naclerio to Nasal Mucosa

This is a "connection" page, showing publications Robert Naclerio has written about Nasal Mucosa.
Connection Strength

6.017
  1. Persistent inflammation and hyperresponsiveness following viral rhinosinusitis. Laryngoscope. 2006 Jul; 116(7):1236-40.
    View in: PubMed
    Score: 0.272
  2. Acute bacterial rhinosinusitis causes hyperresponsiveness to histamine challenge in mice. Arch Otolaryngol Head Neck Surg. 2005 Oct; 131(10):905-10.
    View in: PubMed
    Score: 0.258
  3. Elevation of the nasal mucosal surface temperature after warming of the feet occurs via a neural reflex. Acta Otolaryngol. 2003 Jun; 123(5):627-36.
    View in: PubMed
    Score: 0.220
  4. The nasal passage of subjects with asthma has a decreased ability to warm and humidify inspired air. Am J Respir Crit Care Med. 2001 Nov 01; 164(9):1640-6.
    View in: PubMed
    Score: 0.197
  5. Absence of nasal mucosal atrophy with fluticasone aqueous nasal spray. Arch Otolaryngol Head Neck Surg. 2001 Feb; 127(2):193-9.
    View in: PubMed
    Score: 0.187
  6. Lack of evidence for muscarinic type 2 receptor modulation of the human nasonasal reflex. J Allergy Clin Immunol. 2001 Jan; 107(1):194-5.
    View in: PubMed
    Score: 0.186
  7. Elevation of nasal mucosal temperature increases the ability of the nose to warm and humidify air. Am J Rhinol. 2001 Jan-Feb; 15(1):41-5.
    View in: PubMed
    Score: 0.186
  8. Ipratropium bromide increases the ability of the nose to warm and humidify air. Am J Respir Crit Care Med. 2000 Sep; 162(3 Pt 1):1031-7.
    View in: PubMed
    Score: 0.182
  9. Hot, humid air partially inhibits the nasal response to allergen provocation. Arch Otolaryngol Head Neck Surg. 2000 Jun; 126(6):749-54.
    View in: PubMed
    Score: 0.178
  10. Warming of feet elevates nasal mucosal surface temperature and reduces the early response to nasal challenge with allergen. J Allergy Clin Immunol. 1999 Aug; 104(2 Pt 1):285-93.
    View in: PubMed
    Score: 0.168
  11. Intranasal beclomethasone reduces allergen-induced symptoms and superficial mucosal eosinophilia without affecting submucosal inflammation. Am J Respir Crit Care Med. 1998 Mar; 157(3 Pt 1):899-906.
    View in: PubMed
    Score: 0.153
  12. Treatment with hot, humid air reduces the nasal response to allergen challenge. J Allergy Clin Immunol. 1997 Jan; 99(1 Pt 1):77-86.
    View in: PubMed
    Score: 0.141
  13. Inhibition of the response to nasal provocation with bradykinin by HOE-140: efficacy and duration of action. Can J Physiol Pharmacol. 1995 Jul; 73(7):820-6.
    View in: PubMed
    Score: 0.127
  14. In vivo human models for the study of anticholinergic drugs. J Allergy Clin Immunol. 1995 May; 95(5 Pt 2):1069-79.
    View in: PubMed
    Score: 0.125
  15. Observations on the response of the nasal mucosa to allergens. Otolaryngol Head Neck Surg. 1994 Sep; 111(3 Pt 2):355-63.
    View in: PubMed
    Score: 0.120
  16. Seasonal allergic rhinitis affects sinonasal microbiota. Am J Rhinol Allergy. 2014 Jul-Aug; 28(4):281-6.
    View in: PubMed
    Score: 0.118
  17. Onset and duration of inhibition of ipratropium bromide nasal spray on methacholine-induced nasal secretions. Clin Exp Allergy. 1994 Mar; 24(3):288-90.
    View in: PubMed
    Score: 0.116
  18. Demonstration of bilateral cholinergic secretory response after unilateral nasal cold, dry air challenge. Rhinology. 1993 Sep; 31(3):97-100.
    View in: PubMed
    Score: 0.112
  19. Comparison of the secretory response of the nasal mucosa to methacholine and histamine. J Appl Physiol (1985). 1993 Jun; 74(6):2661-71.
    View in: PubMed
    Score: 0.110
  20. Response of nasal mucosa to histamine or methacholine challenge: use of a quantitative method to examine the modulatory effects of atropine and ipratropium bromide. J Allergy Clin Immunol. 1992 Dec; 90(6 Pt 2):1051-4.
    View in: PubMed
    Score: 0.106
  21. Inhibition of mediator release during the early reaction to antigen. J Allergy Clin Immunol. 1992 Oct; 90(4 Pt 2):715-9.
    View in: PubMed
    Score: 0.105
  22. Intranasal beclomethasone inhibits antigen-induced nasal hyperresponsiveness to histamine. J Allergy Clin Immunol. 1992 Sep; 90(3 Pt 1):373-6.
    View in: PubMed
    Score: 0.104
  23. Ipratropium bromide (Atrovent nasal spray) reduces the nasal response to methacholine. J Allergy Clin Immunol. 1992 Jun; 89(6):1065-75.
    View in: PubMed
    Score: 0.102
  24. Anatomy and physiology of the upper airway. Proc Am Thorac Soc. 2011 Mar; 8(1):31-9.
    View in: PubMed
    Score: 0.094
  25. Histamine stimulation of the nasal mucosa does not induce prostaglandin or leukotriene generation or induce methacholine hyperresponsiveness. Int Arch Allergy Appl Immunol. 1991; 95(2-3):149-55.
    View in: PubMed
    Score: 0.093
  26. Recent studies on the rule of kinins in inflammatory diseases of human airways. Adv Exp Med Biol. 1989; 247A:117-23.
    View in: PubMed
    Score: 0.081
  27. Nasal challenge with cold, dry air induces a late-phase reaction. Am Rev Respir Dis. 1988 Aug; 138(2):400-5.
    View in: PubMed
    Score: 0.079
  28. The influx of inflammatory cells into nasal washings during the late response to antigen challenge. Effect of systemic steroid pretreatment. Am Rev Respir Dis. 1988 Aug; 138(2):406-12.
    View in: PubMed
    Score: 0.079
  29. Nasal challenge with allergen leads to maxillary sinus inflammation. J Allergy Clin Immunol. 2008 May; 121(5):1126-1132.e7.
    View in: PubMed
    Score: 0.077
  30. Nasal ocular reflexes and eye symptoms in patients with allergic rhinitis. Ann Allergy Asthma Immunol. 2008 Mar; 100(3):194-9.
    View in: PubMed
    Score: 0.076
  31. The osmolality of nasal secretions increases when inflammatory mediators are released in response to inhalation of cold, dry air. Am Rev Respir Dis. 1988 Mar; 137(3):625-9.
    View in: PubMed
    Score: 0.076
  32. Elucidating the mechanism underlying the ocular symptoms associated with allergic rhinitis. Allergy Asthma Proc. 2008 Jan-Feb; 29(1):24-8.
    View in: PubMed
    Score: 0.075
  33. Effect of short-term systemic glucocorticoid treatment on human nasal mediator release after antigen challenge. J Clin Invest. 1987 Oct; 80(4):957-61.
    View in: PubMed
    Score: 0.074
  34. Inhibition of mediator release in allergic rhinitis by pretreatment with topical glucocorticosteroids. N Engl J Med. 1987 Jun 11; 316(24):1506-10.
    View in: PubMed
    Score: 0.073
  35. The effect of a topical tricyclic antihistamine on the response of the nasal mucosa to challenge with cold, dry air and histamine. J Allergy Clin Immunol. 1987 Apr; 79(4):599-604.
    View in: PubMed
    Score: 0.072
  36. Epithelial shedding is associated with nasal reactions to cold, dry air. J Allergy Clin Immunol. 2006 Jun; 117(6):1351-8.
    View in: PubMed
    Score: 0.067
  37. Inflammatory mediators in nasal secretions during induced rhinitis. Clin Allergy. 1986 Mar; 16(2):101-10.
    View in: PubMed
    Score: 0.066
  38. Treatment of nasal inflammation decreases the ability of subjects with asthma to condition inspired air. Am J Respir Crit Care Med. 2004 Oct 15; 170(8):863-9.
    View in: PubMed
    Score: 0.059
  39. In vivo demonstration of inflammatory mediator release following nasal challenge with antigen. Eur J Respir Dis Suppl. 1983; 128 (Pt 1):26-32.
    View in: PubMed
    Score: 0.053
  40. Supine position decreases the ability of the nose to warm and humidify air. J Appl Physiol (1985). 2001 Dec; 91(6):2459-65.
    View in: PubMed
    Score: 0.050
  41. Hot, humid air increases cellular influx during the late-phase response to nasal challenge with antigen. Clin Exp Allergy. 2001 Dec; 31(12):1913-22.
    View in: PubMed
    Score: 0.050
  42. As-needed use of fluticasone propionate nasal spray reduces symptoms of seasonal allergic rhinitis. J Allergy Clin Immunol. 2000 Apr; 105(4):732-8.
    View in: PubMed
    Score: 0.044
  43. Relationship between histamine and physiological changes during the early response to nasal antigen provocation. J Appl Physiol (1985). 1999 Feb; 86(2):659-68.
    View in: PubMed
    Score: 0.041
  44. Comparison of nasal mucosal responsiveness to neuronal stimulation in non-allergic and allergic rhinitis: effects of capsaicin nasal challenge. Clin Exp Allergy. 1998 Jan; 28(1):92-100.
    View in: PubMed
    Score: 0.038
  45. Low dose clemastine inhibits sneezing and rhinorrhea during the early nasal allergic reaction. Ann Allergy Asthma Immunol. 1997 Mar; 78(3):307-12.
    View in: PubMed
    Score: 0.036
  46. Pathophysiology of perennial allergic rhinitis. Allergy. 1997; 52(36 Suppl):7-13.
    View in: PubMed
    Score: 0.035
  47. CD4+ lymphocytes are increased in the sinus mucosa of children with chronic sinusitis. Arch Otolaryngol Head Neck Surg. 1996 Oct; 122(10):1071-6.
    View in: PubMed
    Score: 0.035
  48. Effects of loratadine and terfenadine on the induced nasal allergic reaction. Arch Otolaryngol Head Neck Surg. 1996 Mar; 122(3):309-16.
    View in: PubMed
    Score: 0.033
  49. Duration of action of intranasal atropine on methacholine-induced nasal secretions. Arch Otolaryngol Head Neck Surg. 1996 Mar; 122(3):321-3.
    View in: PubMed
    Score: 0.033
  50. Cold dry air-induced rhinitis: effect of inhalation and exhalation through the nose. J Appl Physiol (1985). 1995 Aug; 79(2):467-71.
    View in: PubMed
    Score: 0.032
  51. The histology of allergic rhinitis and its comparison to cellular changes in nasal lavage. Am J Respir Crit Care Med. 1995 Jan; 151(1):136-44.
    View in: PubMed
    Score: 0.031
  52. Nasal challenge with allergen upregulates the local expression of vascular endothelial adhesion molecules. J Allergy Clin Immunol. 1994 Dec; 94(6 Pt 1):1006-16.
    View in: PubMed
    Score: 0.030
  53. Basophils and eosinophils in allergic rhinitis. J Allergy Clin Immunol. 1994 Dec; 94(6 Pt 2):1303-9.
    View in: PubMed
    Score: 0.030
  54. The human nasal response to capsaicin. J Allergy Clin Immunol. 1994 Dec; 94(6 Pt 1):1035-45.
    View in: PubMed
    Score: 0.030
  55. The effect of terfenadine on unilateral nasal challenge with allergen. J Allergy Clin Immunol. 1994 Mar; 93(3):594-605.
    View in: PubMed
    Score: 0.029
  56. Reflex activation of nasal secretion by unilateral inhalation of cold dry air. Am Rev Respir Dis. 1993 Dec; 148(6 Pt 1):1616-22.
    View in: PubMed
    Score: 0.028
  57. Local application of atropine attenuates the upper airway reaction to cold, dry air. Am Rev Respir Dis. 1992 Aug; 146(2):340-6.
    View in: PubMed
    Score: 0.026
  58. The nasal response to histamine challenge: effect of the pollen season and immunotherapy. J Allergy Clin Immunol. 1992 Jul; 90(1):85-91.
    View in: PubMed
    Score: 0.026
  59. Tryptase and histamine as markers to evaluate mast cell activation during the responses to nasal challenge with allergen, cold, dry air, and hyperosmolar solutions. J Allergy Clin Immunol. 1992 Jun; 89(6):1098-110.
    View in: PubMed
    Score: 0.026
  60. Histamine-containing cells obtained from the nose hours after antigen challenge have functional and phenotypic characteristics of basophils. J Immunol. 1992 Apr 01; 148(7):2223-8.
    View in: PubMed
    Score: 0.025
  61. The impact of immunotherapy on the pathophysiology of ragweed pollen allergy. Rhinol Suppl. 1992; 14:52-6.
    View in: PubMed
    Score: 0.025
  62. Antigen-provoked increase in histamine reactivity. Observations on mechanisms. Am Rev Respir Dis. 1991 Sep; 144(3 Pt 1):642-8.
    View in: PubMed
    Score: 0.024
  63. Additional properties of cetirizine, a new H1 antagonist. Allergy Proc. 1991 May-Jun; 12(3):187-91.
    View in: PubMed
    Score: 0.024
  64. Steroid-induced reduction of histamine release does not alter the clinical nasal response to cold, dry air. Am Rev Respir Dis. 1991 Apr; 143(4 Pt 1):761-5.
    View in: PubMed
    Score: 0.024
  65. Pharmacology of nasal provocation with bradykinin: studies of tachyphylaxis, cyclooxygenase inhibition, alpha-adrenergic stimulation, and receptor subtype. Int Arch Allergy Appl Immunol. 1991; 95(4):322-31.
    View in: PubMed
    Score: 0.023
  66. Localized antigen challenge of the nasal mucosa. Arch Otolaryngol Head Neck Surg. 1990 Dec; 116(12):1407-10.
    View in: PubMed
    Score: 0.023
  67. Ragweed IgE and IgG4 antibody in nasal secretions during immunotherapy. Clin Exp Allergy. 1990 Sep; 20(5):571-9.
    View in: PubMed
    Score: 0.023
  68. Studies on the relationships between sensitivity to cold, dry air, hyperosmolal solutions, and histamine in the adult nose. Am Rev Respir Dis. 1990 Jun; 141(6):1428-33.
    View in: PubMed
    Score: 0.022
  69. Effects of a single-dose pretreatment with captopril on the immediate response to nasal challenge with allergen. Int Arch Allergy Appl Immunol. 1990; 93(2-3):165-70.
    View in: PubMed
    Score: 0.022
  70. Kinins are generated in nasal secretions during natural rhinovirus colds. J Infect Dis. 1990 Jan; 161(1):120-3.
    View in: PubMed
    Score: 0.022
  71. Major basic protein and eosinophil-derived neurotoxin concentrations in nasal-lavage fluid after antigen challenge: effect of systemic corticosteroids and relationship to eosinophil influx. J Allergy Clin Immunol. 1989 Sep; 84(3):338-46.
    View in: PubMed
    Score: 0.021
  72. The effect of cetirizine on early allergic response. Laryngoscope. 1989 Jun; 99(6 Pt 1):596-9.
    View in: PubMed
    Score: 0.021
  73. Nasal provocation with bradykinin induces symptoms of rhinitis and a sore throat. Am Rev Respir Dis. 1988 Mar; 137(3):613-6.
    View in: PubMed
    Score: 0.019
  74. Studies of IgE-dependent histamine releasing factors: heterogeneity of IgE. J Immunol. 1987 Jul 15; 139(2):506-12.
    View in: PubMed
    Score: 0.018
  75. Kinin metabolism in human nasal secretions during experimentally induced allergic rhinitis. J Immunol. 1987 Jan 15; 138(2):428-34.
    View in: PubMed
    Score: 0.018
  76. Pharmacology of upper airways challenge. Int Arch Allergy Appl Immunol. 1987; 82(3-4):493-7.
    View in: PubMed
    Score: 0.018
  77. Theophylline reduces histamine release during pollen-induced rhinitis. J Allergy Clin Immunol. 1986 Nov; 78(5 Pt 1):874-6.
    View in: PubMed
    Score: 0.017
  78. Concentrations of glandular kallikrein in human nasal secretions increase during experimentally induced allergic rhinitis. J Immunol. 1986 Aug 15; 137(4):1323-8.
    View in: PubMed
    Score: 0.017
  79. Plasma kallikrein during experimentally induced allergic rhinitis: role in kinin formation and contribution to TAME-esterase activity in nasal secretions. J Immunol. 1986 Aug 01; 137(3):977-82.
    View in: PubMed
    Score: 0.017
  80. Kininogens in nasal secretions after allergen challenge. Adv Exp Med Biol. 1986; 198 Pt B:189-92.
    View in: PubMed
    Score: 0.016
  81. Nasal challenge with cold, dry air results in release of inflammatory mediators. Possible mast cell involvement. J Clin Invest. 1985 Oct; 76(4):1375-81.
    View in: PubMed
    Score: 0.016
  82. Inflammatory mediators in late antigen-induced rhinitis. N Engl J Med. 1985 Jul 11; 313(2):65-70.
    View in: PubMed
    Score: 0.016
  83. Influx of kininogens into nasal secretions after antigen challenge of allergic individuals. J Clin Invest. 1985 Jul; 76(1):191-7.
    View in: PubMed
    Score: 0.016
  84. Mediator release after allergic and physical nasal challenges. Int Arch Allergy Appl Immunol. 1985; 77(1-2):57-63.
    View in: PubMed
    Score: 0.015
  85. In vivo model for the evaluation of topical antiallergic medications. Arch Otolaryngol. 1984 Jan; 110(1):25-7.
    View in: PubMed
    Score: 0.014
  86. Decreased neuropeptide release may play a role in the pathogenesis of nasal polyps. Otolaryngol Head Neck Surg. 1999 Nov; 121(5):585-90.
    View in: PubMed
    Score: 0.011
  87. Unilateral nasal allergen challenge leads to bilateral release of prostaglandin D2. Clin Exp Allergy. 1996 Apr; 26(4):371-8.
    View in: PubMed
    Score: 0.008
  88. A randomized controlled trial of glucocorticoid prophylaxis against experimental rhinovirus infection. J Infect Dis. 1990 Nov; 162(5):1173-7.
    View in: PubMed
    Score: 0.006
  89. Attenuation of allergen sensitivity early in the course of ragweed immunotherapy. J Allergy Clin Immunol. 1989 Sep; 84(3):390-9.
    View in: PubMed
    Score: 0.005
  90. Responses to ragweed-pollen nasal challenge before and after immunotherapy. J Allergy Clin Immunol. 1989 Aug; 84(2):197-205.
    View in: PubMed
    Score: 0.005
  91. Local generation of sulfidopeptide leukotrienes upon nasal provocation with cold, dry air. Am Rev Respir Dis. 1986 Jun; 133(6):1133-7.
    View in: PubMed
    Score: 0.004
  92. Kinins as mediators of human allergic reactions. Adv Exp Med Biol. 1986; 198 Pt B:181-7.
    View in: PubMed
    Score: 0.004
  93. Peptide leukotriene release after antigen challenge in patients sensitive to ragweed. N Engl J Med. 1984 Jun 21; 310(25):1626-30.
    View in: PubMed
    Score: 0.004
  94. Kinins are generated in vivo following nasal airway challenge of allergic individuals with allergen. J Clin Invest. 1983 Nov; 72(5):1678-85.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.